These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3138056)

  • 1. Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo.
    Greenblatt DJ; Harmatz JS; Dorsey C; Shader RI
    Clin Pharmacol Ther; 1988 Sep; 44(3):326-34. PubMed ID: 3138056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.
    Kroboth PD; Folan MM; Lush RM; Chaikin PC; Shukla UA; Barbhaiya R; Salazar DE
    J Clin Psychopharmacol; 1995 Oct; 15(5):306-19. PubMed ID: 8830061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam.
    Busto UE; Kaplan HL; Wright CE; Gomez-Mancilla B; Zawertailo L; Greenblatt DJ; Sellers EM
    J Clin Psychopharmacol; 2000 Dec; 20(6):628-35. PubMed ID: 11106134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytics and memory: a comparison of lorazepam and alprazolam.
    Kumar R; Mac DS; Gabrielli WF; Goodwin DW
    J Clin Psychiatry; 1987 Apr; 48(4):158-60. PubMed ID: 3558328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations and clinical effects after single oral doses of prazepam, clorazepate, and diazepam.
    Shader RI; Pary RJ; Harmatz JS; Allison S; Locniskar A; Greenblatt DJ
    J Clin Psychiatry; 1984 Oct; 45(10):411-3. PubMed ID: 6148339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive effects of beta-adrenergic antagonists after single doses: pharmacokinetics and pharmacodynamics of propranolol, atenolol, lorazepam, and placebo.
    Greenblatt DJ; Scavone JM; Harmatz JS; Engelhardt N; Shader RI
    Clin Pharmacol Ther; 1993 May; 53(5):577-84. PubMed ID: 8098277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation.
    Pomara N; Tun H; DaSilva D; Hernando R; Deptula D; Greenblatt DJ
    Psychopharmacol Bull; 1998; 34(2):139-53. PubMed ID: 9640992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a single oral dose of lorazepam and alprazolam on reaction times in young healthy volunteers.
    Crombez G; Kupers R; Adriaensen H
    Acta Anaesthesiol Belg; 1991; 42(2):79-84. PubMed ID: 1927238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC
    Encephale; 1984; 10(3):135-8. PubMed ID: 6389091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder.
    Cohn JB; Wilcox CS
    Pharmacotherapy; 1984; 4(2):93-8. PubMed ID: 6144090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of alprazolam and lorazepam on catecholaminergic and cardiovascular activity during supine rest, mental load and orthostatic challenge.
    van den Berg F; Tulen JH; Boomsma F; Noten JB; Moleman P; Pepplinkhuizen L
    Psychopharmacology (Berl); 1996 Nov; 128(1):21-30. PubMed ID: 8944402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects.
    Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Harmatz JS; Shader RI
    J Clin Pharmacol; 1998 Jan; 38(1):14-21. PubMed ID: 9597554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sedative effects and impaired learning and recall after single oral doses of lorazepam.
    Shader RI; Dreyfuss D; Gerrein JR; Harmatz JS; Allison SJ; Greenblatt DJ
    Clin Pharmacol Ther; 1986 May; 39(5):526-9. PubMed ID: 3698460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic analysis of sedative and amnesic effects of lorazepam in healthy volunteers.
    Blin O; Simon N; Jouve E; Habib M; Gayraud D; Durand A; Bruguerolle B; Pisano P
    Clin Neuropharmacol; 2001; 24(2):71-81. PubMed ID: 11307041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity to alprazolam in females with a paternal history of alcoholism.
    Evans SM; Levin FR; Fischman MW
    Psychopharmacology (Berl); 2000 Jun; 150(2):150-62. PubMed ID: 10907668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys.
    Friedman H; Redmond DE; Greenblatt DJ
    Psychopharmacology (Berl); 1991; 104(1):103-5. PubMed ID: 1881994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests.
    Vermeeren A; Jackson JL; Muntjewerff ND; Quint PJ; Harrison EM; O'Hanlon JF
    Psychopharmacology (Berl); 1995 Mar; 118(1):1-9. PubMed ID: 7597114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alprazolam and lorazepam effects on memory acquisition and retrieval processes.
    Block RI; Berchou R
    Pharmacol Biochem Behav; 1984 Feb; 20(2):233-41. PubMed ID: 6144110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the post-prandial state.
    Scavone JM; Greenblatt DJ; Goddard JE; Friedman H; Harmatz JS; Shader RI
    Eur J Clin Pharmacol; 1992; 42(4):439-43. PubMed ID: 1516609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lorazepam vs. alprazolam in the treatment of panic disorder.
    Schweizer E; Pohl R; Balon R; Fox I; Rickels K; Yeragani VK
    Pharmacopsychiatry; 1990 Mar; 23(2):90-3. PubMed ID: 2187213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.